Literature DB >> 11347963

Characterisation of inter- and intra-molecular interactions of the dengue virus RNA dependent RNA polymerase as potential drug targets.

S G Vasudevan1, M Johansson, A J Brooks, L E Llewellyn, D A Jans.   

Abstract

Our research is directed towards enhancing the understanding of the molecular biology of dengue virus replication with the ultimate goal being to develop novel antiviral strategies based on preventing critical inter- or intra-molecular interactions required for the normal virus life cycle. The viral RNA-dependent RNA polymerase (NS5) and the viral helicase (NS3) interaction offers a possible target for inhibitors to bind and prevent replication. In this study the yeast-two hybrid system was used to show that a small region of NS5 interacts with NS3, and also with the cellular nuclear transport receptor importin-beta. Furthermore, intramolecular interaction between the two putative domains of NS5 can also be detected by the yeast two-hybrid assay. We have also modified the colony lift assay for the beta-galactosidase reporter activity in intact yeast cells which reflects the strength of interaction between two proteins to a microtiter plate format. This assay offers a unique opportunity to screen for small molecule compounds that block physiologically important interactions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11347963     DOI: 10.1016/s0014-827x(01)01014-x

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  10 in total

1.  Crystal structure of the NS3 protease-helicase from dengue virus.

Authors:  Dahai Luo; Ting Xu; Cornelia Hunke; Gerhard Grüber; Subhash G Vasudevan; Julien Lescar
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

2.  Interaction of TIA-1/TIAR with West Nile and dengue virus products in infected cells interferes with stress granule formation and processing body assembly.

Authors:  Mohamed M Emara; Margo A Brinton
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-14       Impact factor: 11.205

3.  Substitution of NS5 N-terminal domain of dengue virus type 2 RNA with type 4 domain caused impaired replication and emergence of adaptive mutants with enhanced fitness.

Authors:  Tadahisa Teramoto; Siwaporn Boonyasuppayakorn; Misty Handley; Kyung H Choi; Radhakrishnan Padmanabhan
Journal:  J Biol Chem       Date:  2014-06-05       Impact factor: 5.157

Review 4.  Host-Virus Interaction of ZIKA Virus in Modulating Disease Pathogenesis.

Authors:  Nanda Kishore Routhu; Siddappa N Byrareddy
Journal:  J Neuroimmune Pharmacol       Date:  2017-03-27       Impact factor: 4.147

Review 5.  Organization of the Flavivirus RNA replicase complex.

Authors:  Carolin Brand; Martin Bisaillon; Brian J Geiss
Journal:  Wiley Interdiscip Rev RNA       Date:  2017-08-16       Impact factor: 9.957

Review 6.  Regulation of flavivirus RNA synthesis and capping.

Authors:  Bejan J Saeedi; Brian J Geiss
Journal:  Wiley Interdiscip Rev RNA       Date:  2013-08-08       Impact factor: 9.957

7.  Crystal Structure of the full-length Japanese encephalitis virus NS5 reveals a conserved methyltransferase-polymerase interface.

Authors:  Guoliang Lu; Peng Gong
Journal:  PLoS Pathog       Date:  2013-08-08       Impact factor: 6.823

8.  Inhibitor designing, virtual screening, and docking studies for methyltransferase: A potential target against dengue virus.

Authors:  Jagbir Singh; Mahesh Kumar; Rani Mansuri; Ganesh Chandra Sahoo; Aakash Deep
Journal:  J Pharm Bioallied Sci       Date:  2016 Jul-Sep

Review 9.  Inhibitors compounds of the flavivirus replication process.

Authors:  Leidy L García; Leonardo Padilla; Jhon C Castaño
Journal:  Virol J       Date:  2017-05-15       Impact factor: 4.099

10.  Identification of new protein interactions between dengue fever virus and its hosts, human and mosquito.

Authors:  Dumrong Mairiang; Huamei Zhang; Ann Sodja; Thilakam Murali; Prapat Suriyaphol; Prida Malasit; Thawornchai Limjindaporn; Russell L Finley
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.